DACHA STRATEGIC
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which d… Read more
DACHA STRATEGIC (7DC) - Total Liabilities
Latest total liabilities as of June 2025: €7.18 Million EUR
Based on the latest financial reports, DACHA STRATEGIC (7DC) has total liabilities worth €7.18 Million EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
DACHA STRATEGIC - Total Liabilities Trend (2019–2024)
This chart illustrates how DACHA STRATEGIC's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
DACHA STRATEGIC Competitors by Total Liabilities
The table below lists competitors of DACHA STRATEGIC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Pharmaniaga Bhd
KLSE:7081
|
Malaysia | RM1.79 Billion |
|
iClick Interactive Asia Group
NASDAQ:ICLK
|
USA | $122.45 Million |
|
Sandhar Technologies Limited
NSE:SANDHAR
|
India | ₹19.74 Billion |
|
Community Bancorp. Common Stock
OTCQX:CMTV
|
USA | $1.11 Billion |
|
Inmocemento, S.A.
MC:IMC
|
Spain | €1.65 Billion |
|
Sunrise Realty Trust, Inc.
NASDAQ:SUNS
|
USA | $74.22 Million |
|
Solusi Tunas Pratama Tbk
JK:SUPR
|
Indonesia | Rp2.40 Trillion |
Liability Composition Analysis (2019–2024)
This chart breaks down DACHA STRATEGIC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.96 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.19 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.16 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how DACHA STRATEGIC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for DACHA STRATEGIC (2019–2024)
The table below shows the annual total liabilities of DACHA STRATEGIC from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €8.76 Million | +57.66% |
| 2023-12-31 | €5.56 Million | -3.20% |
| 2022-12-31 | €5.74 Million | +31.58% |
| 2021-12-31 | €4.36 Million | +33.01% |
| 2020-12-31 | €3.28 Million | +46.54% |
| 2019-12-31 | €2.24 Million | -- |